banner

News Releases

None | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
Date Title
12/15/15
ACADIA Pharmaceuticals Appoints Julian C. Baker to Board of Directors
11/30/15
ACADIA Pharmaceuticals Appoints Srdjan (Serge) Stankovic, M.D., M.S.P.H., as Executive Vice President, Head of Research and Development
11/30/15
ACADIA Pharmaceuticals Appoints Edmund P. Harrigan, M.D., to Board of Directors
11/05/15
ACADIA Pharmaceuticals Reports Third Quarter 2015 Financial Results
11/04/15
ACADIA Pharmaceuticals to Present at the 24th Annual Credit Suisse Healthcare Conference on November 10, 2015
11/02/15
ACADIA Pharmaceuticals Announces FDA Priority Review of NUPLAZID™ (Pimavanserin) New Drug Application for Parkinson’s Disease Psychosis
10/29/15
ACADIA Pharmaceuticals to Announce Third Quarter Financial Results on November 5, 2015
09/22/15
ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2015 Healthcare Conference on September 29, 2015
09/03/15
ACADIA Pharmaceuticals Appoints Steve Davis as Chief Executive Officer
09/03/15
ACADIA Pharmaceuticals Submits New Drug Application for NUPLAZID™ for the Treatment of Parkinson’s Disease Psychosis
08/06/15
ACADIA Pharmaceuticals Reports Second Quarter 2015 Financial Results
08/06/15
ACADIA Pharmaceuticals Announces Publication of Data from Its -015 Open Label Safety Study in Parkinson’s Disease Psychosis in the Journal of the American Medical Directors Association
08/05/15
ACADIA Pharmaceuticals Announces Senior Management Appointments in Manufacturing, Quality, Compliance, Access and Reimbursement and Business Development
07/30/15
ACADIA Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2015
06/17/15
ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 24, 2015
06/16/15
ACADIA Pharmaceuticals Presents Integrated Data from Its Phase III Program with NUPLAZID™ (Pimavanserin) for Parkinson’s Disease Psychosis at the 19th International Congress of Parkinson’s Disease and Movement Disorders
05/26/15
ACADIA Pharmaceuticals to Present at the Jefferies 2015 Healthcare Conference on June 2, 2015
05/07/15
ACADIA Pharmaceuticals Reports First Quarter 2015 Financial Results
05/06/15
ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference on May 13, 2015
04/30/15
ACADIA Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2015
04/07/15
ACADIA Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference on April 14, 2015
03/26/15
ACADIA Pharmaceuticals Appoints Daniel Soland to Board of Directors
03/11/15
ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer
03/11/15
ACADIA Pharmaceuticals Updates Planned Timing of NUPLAZID™ NDA Submission
02/26/15
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014
02/24/15
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
02/19/15
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015
01/06/15
ACADIA Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on January 13, 2015